Cardlytics (CDLX) Tops Q2 EPS by 49c

Cardlytics (NASDAQ: CDLX) reported Q2 EPS of ($0.24), $0.49 better than the analyst estimate of ($0.73). Revenue for the quarter came in at $76.7 million versus the consensus estimate of $69.11 million.

For earnings history and earnings-related data on Cardlytics (CDLX) click here.

You May Also Be Interested In

• Klarna shares tumble on weak full-year revenue guidance
• Klarna Group plc (KLAR) Tops Q2 EPS by 6c, Beats on Revenue; Offers FY26 Revenue Guidance
• GLJ Research on Sell Rated Tesla (TSLA): 'We now see FSD as the main reason TSLA’s stock will bleed lower this year'